Diphtheria Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Diphtheria Industry Market Size Be by 2025?
In the last few years, there has been robust growth in the market size of diphtheria. It is set to expand from $8.91 billion in 2024 to $9.51 billion in 2025 with a compound annual growth rate (CAGR) of 6.7%. The significant growth observed in the historic period is due to factors like vaccine development, immunization drives, rising awareness and improvements in healthcare infrastructure.

What's the Long-Term Growth Forecast for the Diphtheria Market Size Through 2029?
There is a forecast of robust expansion in the diphtheria market size in the coming years with an expected increase to $12.35 billion in 2029, maintaining a compound annual growth rate (CAGR) of 6.8%. The growth during this forecast period can be ascribed to increased outbreaks, booster vaccination initiatives, worldwide travel and migration, and public health readiness. The forecast period will also witness major trends such as combined vaccines, telemedicine for immunization, initiatives to ensure vaccine equity, and collaborations between public and private entities.

View the full report here:
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

What Are the Key Growth Drivers Fueling the Diphtheria Market Expansion?
The diphtheria market anticipates growth due to the increasing prevalence of bacterial infections. Bacterial infections can be described as health complications caused by the growth of bacteria or toxins in the body. Diphtheria, a severe infection, is triggered by bacterial species that weaken the immune system and boost the growth of Corynebacterium diphtheria. As an example, in the fiscal year 2022 to 2023, the NHS acute trusts in England documented a significant 38,757 cases of E. coli bacteremia; amongst these, 7,881 instances (20.3%) were identified as hospital-acquired infections, according to the UK government website, GOV.UK, September 2024. Consequently, the diphtheria market will be bolstered by the rising incidence of bacterial infections. The upward trend of immunization programs is anticipated to fuel the expansion of the diphtheria market. Immunization programs are platforms designed to safeguard individuals from vaccine-preventable diseases by providing vaccinations. These initiatives aim to mitigate disease, disability, and death caused by preventable diseases. Diphtheria and a variety of other vaccines are supplied to people through immunization programs in different countries. The United Nations International Children's Emergency Fund reported in July 2023, that the global coverage rates for the third dose of the Diphtheria, Tetanus, Pertussis (DTP3) vaccination showed growth, rising from 81% in 2021 to 84% in 2022 through immunization programs. Therefore, the driving force for the diphtheria market's growth is the upward trend in immunization programs.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

What Are the Key Trends Driving Diphtheria Market Growth?
Leading corporations in the diphtheria market are advancing by introducing new drugs and gaining authorizations to maintain their market standing. For example, in October 2022, UK's biotechnology and pharmaceutical firm GlaxoSmithKline PLC publicly revealed that the US Food and Drug Administration (FDA) has granted approval for BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, adsorbed; Tdap) to be used for immunization from the third month of pregnancy onwards to prevent pertussis (whooping cough) in infants below two months old. The Tdap vaccine given during pregnancy provides maximum protection against whooping cough for newborns during their initial months. This vaccine allows the transfer of protective antibodies from the mother to the child when administered to pregnant women.

How Is the Diphtheria Market Segmented?
The diphtheria market covered in this report is segmented -

1) By Type: Diphtheria, Skin Diphtheria, Other Types
2) By Diagnosis: Physical Examination, Throat Culture, Other Diagnosis
3) By Treatment: Antibiotics, Antitoxin, Other Treatments
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Diphtheria: Respiratory Diphtheria, Non-respiratory Diphtheria
2) By Skin Diphtheria: Cutaneous Diphtheria
3) By Other Types: Diphtheritic Myocarditis, Diphtheritic Neuritis

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13016&type=smp

Which Companies Are Leading the Charge in Diphtheria Market Innovation?
Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

Which Regions Are Leading the Global Diphtheria Market in Revenue?
Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13016

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.